20 October 2021 2 Min Read
Vaccine maker Biovac in search of R2bn in funding to lift output
Biovac says its strategy is not limited to boosting production volumes, and includes extending its range of products
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In